User profiles for Simani Gaseitsiwe

Simani Gaseitsiwe

Research Associate, Harvard School of Public Health and Laboratory Director Botswana …
Verified email at bhp.org.bw
Cited by 5380

[HTML][HTML] Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

…, A Glass, DP Martin, A Rambaut, S Gaseitsiwe… - Nature, 2022 - nature.com
The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves.
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …

[HTML][HTML] Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa

…, A Rambaut, O Laguda-Akingba, S Gaseitsiwe… - Nature medicine, 2022 - nature.com
Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth …

[HTML][HTML] An early warning system for emerging SARS-CoV-2 variants

…, J Druce, P Effler, I El Masry, A Faye, S Gaseitsiwe… - Nature medicine, 2022 - nature.com
Global sequencing and surveillance capacity for SARS-CoV-2 must be strengthened and
combined with multidisciplinary studies of infectivity, virulence and immune escape, in order …

Continued emergence and evolution of Omicron in South Africa: New BA. 4 and BA. 5 lineages

…, A Glass, DP Martin, A Rambaut, S Gaseitsiwe… - MedRxiv, 2022 - medrxiv.org
South Africa’s fourth COVID-19 wave was driven predominantly by three lineages (BA.1, BA.2
and BA.3) of the SARS-CoV-2 Omicron variant of concern. We have now identified two …

[HTML][HTML] Universal testing, expanded treatment, and incidence of HIV infection in Botswana

…, C Sexton, E Raizes, S Gaseitsiwe… - … England Journal of …, 2019 - Mass Medical Soc
Background The feasibility of reducing the population-level incidence of human immunodeficiency
virus (HIV) infection by increasing community coverage of antiretroviral therapy (ART) …

[HTML][HTML] African-led health research and capacity building-is it working?

…, E Hunter, W Kilembe, E Karita, S Gaseitsiwe… - BMC Public Health, 2020 - Springer
Background Africa bears a disproportionately high burden of globally significant disease but
has lagged in knowledge production to address its health challenges. In this contribution, …

H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa

…, FM Fadlelmola, F Gaboun, S Gaseitsiwe… - Genome …, 2016 - genome.cshlp.org
The application of genomics technologies to medicine and biomedical research is
increasing in popularity, made possible by new high-throughput genotyping and sequencing …

Point-of-care Cepheid Xpert HIV-1 viral load test in rural African communities is feasible and reliable

…, CN Maphorisa, B Seraise, S Gaseitsiwe… - Journal of clinical …, 2016 - Am Soc Microbiol
Routine monitoring of HIV-1 RNA or viral load (VL) in patients on antiretroviral therapy (ART)
is important, but there are multiple impediments to VL testing in resource-constrained …

Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana

…, L Stevens, SJ Heymann, T Ndung'u, S Gaseitsiwe… - Aids, 2006 - journals.lww.com
Background: Single-dose nevirapine given to women and infants reduces mother-to-child
HIV transmission, but nevirapine resistance develops in a large percentage of women. …

High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based …

…, T Gaolathe, M Mine, S Gaseitsiwe… - Antimicrobial agents …, 2006 - Am Soc Microbiol
We analyzed the reverse transcriptase genotypes of human immunodeficiency virus type 1
subtype C viruses isolated from 23 patients in Botswana treated with didanosine-based …